AnaptysBio Inc (ANAB)
20.14
-1.54
(-7.13%)
USD |
NASDAQ |
Nov 04, 13:04
AnaptysBio 1 Year Total Returns (Daily): 31.08% for Nov. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 01, 2024 | 31.08% |
October 31, 2024 | 32.62% |
October 30, 2024 | 34.51% |
October 29, 2024 | 88.38% |
October 28, 2024 | 86.48% |
October 25, 2024 | 81.78% |
October 24, 2024 | 82.55% |
October 23, 2024 | 97.89% |
October 22, 2024 | 94.74% |
October 21, 2024 | 95.96% |
October 18, 2024 | 89.08% |
October 17, 2024 | 85.94% |
October 16, 2024 | 87.31% |
October 15, 2024 | 76.59% |
October 14, 2024 | 84.39% |
October 11, 2024 | 70.80% |
October 10, 2024 | 63.35% |
October 09, 2024 | 57.54% |
October 08, 2024 | 68.05% |
October 07, 2024 | 71.43% |
October 04, 2024 | 84.07% |
October 03, 2024 | 90.07% |
October 02, 2024 | 98.53% |
October 01, 2024 | 93.82% |
September 30, 2024 | 86.53% |
Date | Value |
---|---|
September 27, 2024 | 72.55% |
September 26, 2024 | 79.12% |
September 25, 2024 | 86.61% |
September 24, 2024 | 106.8% |
September 23, 2024 | 110.8% |
September 20, 2024 | 113.8% |
September 19, 2024 | 102.4% |
September 18, 2024 | 89.78% |
September 17, 2024 | 92.31% |
September 16, 2024 | 98.56% |
September 13, 2024 | 106.6% |
September 12, 2024 | 95.41% |
September 11, 2024 | 80.83% |
September 10, 2024 | 75.26% |
September 09, 2024 | 77.43% |
September 06, 2024 | 80.22% |
September 05, 2024 | 87.42% |
September 04, 2024 | 88.48% |
September 03, 2024 | 83.15% |
August 30, 2024 | 93.84% |
August 29, 2024 | 85.14% |
August 28, 2024 | 83.12% |
August 27, 2024 | 83.74% |
August 26, 2024 | 86.13% |
August 23, 2024 | 85.32% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-87.44%
Minimum
Nov 08 2019
192.1%
Maximum
Nov 10 2020
-0.72%
Average
-5.35%
Median
1 Year Total Returns (Daily) Benchmarks
Regeneron Pharmaceuticals Inc | 6.61% |
Ligand Pharmaceuticals Inc | 106.5% |
Agios Pharmaceuticals Inc | 110.7% |
ADMA Biologics Inc | 450.3% |
Black Diamond Therapeutics Inc | 56.64% |